NO157369C - Fremgangsmaate for fremstilling av en dipyridamol-retardform. - Google Patents
Fremgangsmaate for fremstilling av en dipyridamol-retardform.Info
- Publication number
- NO157369C NO157369C NO810061A NO810061A NO157369C NO 157369 C NO157369 C NO 157369C NO 810061 A NO810061 A NO 810061A NO 810061 A NO810061 A NO 810061A NO 157369 C NO157369 C NO 157369C
- Authority
- NO
- Norway
- Prior art keywords
- preparing
- procedure
- retard form
- dipyridamol
- dipyridamol retard
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19803000979 DE3000979A1 (de) | 1980-01-12 | 1980-01-12 | Neue dipyridamol-retardformen und verfahren zu ihrer herstellung |
Publications (3)
Publication Number | Publication Date |
---|---|
NO810061L NO810061L (no) | 1981-07-13 |
NO157369B NO157369B (no) | 1987-11-30 |
NO157369C true NO157369C (no) | 1988-03-16 |
Family
ID=6091926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO810061A NO157369C (no) | 1980-01-12 | 1981-01-09 | Fremgangsmaate for fremstilling av en dipyridamol-retardform. |
Country Status (32)
Country | Link |
---|---|
US (1) | US4367217A (pl) |
EP (1) | EP0032562B1 (pl) |
JP (1) | JPS56103111A (pl) |
AR (1) | AR221983A1 (pl) |
AT (1) | ATE6585T1 (pl) |
AU (1) | AU539618B2 (pl) |
CA (1) | CA1148084A (pl) |
CS (1) | CS232713B2 (pl) |
DD (1) | DD156943A5 (pl) |
DE (2) | DE3000979A1 (pl) |
DK (1) | DK158539C (pl) |
ES (1) | ES8207428A1 (pl) |
FI (1) | FI78835C (pl) |
GB (1) | GB2067073B (pl) |
GR (1) | GR73102B (pl) |
HK (1) | HK62184A (pl) |
HU (1) | HU184366B (pl) |
IE (1) | IE50807B1 (pl) |
IL (1) | IL61887A (pl) |
IN (1) | IN155158B (pl) |
KE (1) | KE3402A (pl) |
MA (1) | MA19040A1 (pl) |
MY (1) | MY8500559A (pl) |
NO (1) | NO157369C (pl) |
NZ (1) | NZ195994A (pl) |
OA (1) | OA06720A (pl) |
PH (1) | PH17063A (pl) |
PL (1) | PL129290B1 (pl) |
PT (1) | PT72330B (pl) |
SG (1) | SG28184G (pl) |
YU (1) | YU42549B (pl) |
ZA (1) | ZA811661B (pl) |
Families Citing this family (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2470599A1 (fr) * | 1979-12-07 | 1981-06-12 | Panoz Donald | Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus |
DE3264867D1 (en) * | 1981-04-27 | 1985-08-29 | Haessle Ab | New pharmaceutical preparation |
DE3124090A1 (de) | 1981-06-19 | 1983-01-05 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue orale dipyridamolformen |
DE3126703A1 (de) * | 1981-07-07 | 1983-01-27 | Dr. Karl Thomae Gmbh, 7950 Biberach | Bromhexin-retardform und verfahren zu ihrer herstellung |
IE54171B1 (en) * | 1982-06-22 | 1989-07-05 | Univ Glasgow | Device for introducing nutrients and/or therapeutic materials into ruminant animals |
US4704284A (en) * | 1982-08-12 | 1987-11-03 | Pfizer Inc. | Long-acting matrix tablet formulations |
DE3237575A1 (de) * | 1982-10-09 | 1984-04-12 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue orale mopidamolformen |
DK58983D0 (da) * | 1983-02-11 | 1983-02-11 | Leo Pharm Prod Ltd | Farmaceutisk praeparat |
DE3306250A1 (de) * | 1983-02-23 | 1984-08-23 | Basf Ag, 6700 Ludwigshafen | Sphaerische einkristalle fuer pharmazeutische zwecke |
IE55745B1 (en) * | 1983-04-06 | 1991-01-02 | Elan Corp Plc | Sustained absorption pharmaceutical composition |
HU191542B (en) * | 1983-04-08 | 1987-03-30 | Boehringer Ingelheim Ltd | Process for production of pastiles containing dipyridamel independent from ph with regulated output of the active substance |
JPS6051106A (ja) * | 1983-08-31 | 1985-03-22 | Yamanouchi Pharmaceut Co Ltd | 塩酸アモスラロ−ル持続性製剤 |
IE56459B1 (en) * | 1983-12-21 | 1991-08-14 | Elan Corp Ltd | Controlled absorption pharmaceutical formulation |
GB8414220D0 (en) * | 1984-06-04 | 1984-07-11 | Sterwin Ag | Medicaments in unit dose form |
GB8414221D0 (en) * | 1984-06-04 | 1984-07-11 | Sterwin Ag | Unit dosage form |
US4867984A (en) * | 1984-11-06 | 1989-09-19 | Nagin K. Patel | Drug in bead form and process for preparing same |
DE3627423A1 (de) * | 1986-08-13 | 1988-02-18 | Thomae Gmbh Dr K | Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw. deren physiologisch vertraegliche salze, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung der thrombusbildung |
SE460947B (sv) * | 1986-08-26 | 1989-12-11 | Lejus Medical Ab | En multiple-unit-dos komposition av l-dopa |
WO1988002629A1 (en) * | 1986-10-16 | 1988-04-21 | American Health Products Corporation | 2',3'-didesoxyadenosine composition |
US5811128A (en) * | 1986-10-24 | 1998-09-22 | Southern Research Institute | Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor |
US5075109A (en) * | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
US4800087A (en) * | 1986-11-24 | 1989-01-24 | Mehta Atul M | Taste-masked pharmaceutical compositions |
IL84599A0 (en) * | 1986-12-09 | 1988-04-29 | Byk Gulden Lomberg Chem Fab | Pharmaceutical composition containing urapidil and process for the preparation thereof |
DE3812799A1 (de) * | 1988-04-16 | 1989-10-26 | Sanol Arznei Schwarz Gmbh | Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung |
GB8813032D0 (en) * | 1988-06-02 | 1988-07-06 | Boehringer Ingelheim Int | Antiviral pharmaceutical composition |
US5202128A (en) * | 1989-01-06 | 1993-04-13 | F. H. Faulding & Co. Limited | Sustained release pharmaceutical composition |
US5196203A (en) * | 1989-01-06 | 1993-03-23 | F. H. Faulding & Co. Limited | Theophylline dosage form |
US5084278A (en) * | 1989-06-02 | 1992-01-28 | Nortec Development Associates, Inc. | Taste-masked pharmaceutical compositions |
AT397345B (de) * | 1990-04-04 | 1994-03-25 | Chemiefaser Lenzing Ag | Pharmazeutisches präparat mit verzögerter wirkstofffreisetzung auf basis von hemicellulosen |
JP3426230B2 (ja) * | 1991-05-20 | 2003-07-14 | アベンティス・ファーマスーティカルズ・インコーポレイテッド | 複数層の制御放出処方剤 |
SG42869A1 (en) * | 1992-08-05 | 1997-10-17 | Faulding F H & Co Ltd | Pelletised pharmaceutical composition |
US6676967B1 (en) * | 1993-09-20 | 2004-01-13 | Kos Pharmaceuticals, Inc. | Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia |
US6129930A (en) * | 1993-09-20 | 2000-10-10 | Bova; David J. | Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night |
US20060263428A1 (en) * | 1993-09-20 | 2006-11-23 | Eugenio Cefali | Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics |
US6818229B1 (en) | 1993-09-20 | 2004-11-16 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia |
US6080428A (en) | 1993-09-20 | 2000-06-27 | Bova; David J. | Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
US6746691B2 (en) | 1993-09-20 | 2004-06-08 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics |
US20060068001A1 (en) * | 1996-03-25 | 2006-03-30 | Wyeth | Extended release formulation |
WO2000018396A1 (fr) * | 1998-09-25 | 2000-04-06 | Sankyo Company, Limited | PREPARATIONS A BASE D'INHIBITEUR DE HMG-CoA |
JP2000159692A (ja) * | 1998-09-25 | 2000-06-13 | Sankyo Co Ltd | HMG―CoAレダクタ―ゼ阻害薬含有製剤 |
JP2003508422A (ja) | 1999-09-02 | 2003-03-04 | ノストラム・ファーマスーティカルズ・インコーポレイテッド | 放出制御ペレット製剤 |
WO2001024781A2 (en) * | 1999-10-07 | 2001-04-12 | Novaneuron Inc. | Gene necessary for striatal function, uses thereof, and compounds for modulating same |
EP1093814A1 (en) * | 1999-10-22 | 2001-04-25 | Boehringer Ingelheim Pharma KG | Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
DK1276470T3 (da) | 2000-04-20 | 2007-06-18 | Novartis Ag | Smagskaskerende overtrækssammensætning |
US7064130B2 (en) * | 2001-04-20 | 2006-06-20 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders |
US7183410B2 (en) * | 2001-08-02 | 2007-02-27 | Bidachem S.P.A. | Stable polymorph of flibanserin |
US20030060475A1 (en) * | 2001-08-10 | 2003-03-27 | Boehringer Ingelheim Pharma Kg | Method of using flibanserin for neuroprotection |
PL370764A1 (pl) | 2001-10-05 | 2005-05-30 | Combinatorx, Incorporated | Kombinacje przeznaczone do leczenia schorzeń zapalnych o podłożu immunologicznym |
DE10149674A1 (de) | 2001-10-09 | 2003-04-24 | Apogepha Arzneimittel Gmbh | Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung |
UA78974C2 (en) * | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
US20030181488A1 (en) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof |
US20040048877A1 (en) * | 2002-05-22 | 2004-03-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions containing flibanserin |
WO2004069254A2 (en) | 2003-02-07 | 2004-08-19 | Boehringer Ingelheim International Gmbh | Use of dipyridamole or mopidamole for treatment and prevention of mmp-9-dependent disorders |
DE10306179A1 (de) | 2003-02-13 | 2004-08-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe |
EP2062580A1 (en) | 2003-04-24 | 2009-05-27 | Boehringer Ingelheim International GmbH | Use of dipyridamole or mopidamole for treatment and prevention of thromboembolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of trombin receptors |
DE10339862A1 (de) * | 2003-08-29 | 2005-03-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel |
US20050112199A1 (en) * | 2003-09-24 | 2005-05-26 | Mahesh Padval | Therapeutic regimens for administering drug combinations |
TW200517114A (en) | 2003-10-15 | 2005-06-01 | Combinatorx Inc | Methods and reagents for the treatment of immunoinflammatory disorders |
US20050239798A1 (en) * | 2004-04-22 | 2005-10-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for the treatment of premenstrual and other female sexual disorders |
RU2006143838A (ru) * | 2004-05-13 | 2008-06-20 | БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) | Применение дипиридамола для лечения устойчивости к ингибиторам тромбоцитов |
US20060025420A1 (en) * | 2004-07-30 | 2006-02-02 | Boehringer Ingelheimn International GmbH | Pharmaceutical compositions for the treatment of female sexual disorders |
EP1858515A2 (en) * | 2005-03-04 | 2007-11-28 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders |
WO2006096439A2 (en) * | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases |
AU2006226293B2 (en) | 2005-03-22 | 2011-04-07 | Losan Pharma Gmbh | Solubilized ibuprofen |
JP2008540673A (ja) * | 2005-05-19 | 2008-11-20 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 薬剤誘発性性機能不全の治療方法 |
JP2009503020A (ja) | 2005-08-03 | 2009-01-29 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 肥満症の治療におけるフリバンセリンの使用 |
US20070087056A1 (en) * | 2005-08-09 | 2007-04-19 | Claudia Guthmann | Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility |
CN102198273A (zh) * | 2005-08-22 | 2011-09-28 | 诺瓦提斯公司 | 包含pH依赖性药物、pH调节剂和阻滞剂的药物组合物 |
GB0517204D0 (en) * | 2005-08-22 | 2005-09-28 | Novartis Ag | Organic compounds |
EP1945214A1 (en) * | 2005-10-29 | 2008-07-23 | Boehringer Ingelheim International GmbH | Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
US20070105869A1 (en) * | 2005-11-08 | 2007-05-10 | Stephane Pollentier | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders |
CN103211779B (zh) * | 2006-01-27 | 2016-03-16 | 阿代尔制药股份有限公司 | 包含弱碱性选择性5-羟色胺5-ht3阻断剂和有机酸的药物递送系统 |
ES2533563T5 (es) | 2006-01-27 | 2018-07-24 | Adare Pharmaceuticals, Inc. | Sistemas de suministro de fármacos que comprenden fármacos débilmente básicos y ácidos orgánicos |
WO2007092026A1 (en) | 2006-02-09 | 2007-08-16 | Teva Pharmaceutical Industries Ltd. | Dipyridamole extended-release formulations and process for preparing same |
MX2008013827A (es) * | 2006-05-09 | 2008-11-10 | Boehringer Ingelheim Int | Uso de flibanserina para el tratamiento de trastornos posmenopausicos del deseo sexual. |
CA2652773A1 (en) * | 2006-05-22 | 2007-12-06 | Combinatorx, Incorporated | Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein, interleukin-6, or interferon-gamma levels |
DE602007004615D1 (de) | 2006-06-30 | 2010-03-18 | Boehringer Ingelheim Pharma | Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen |
JP2009543839A (ja) * | 2006-07-14 | 2009-12-10 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 女性の性的障害を治療するためのフリバンセリンの使用 |
JP5793828B2 (ja) | 2006-08-14 | 2015-10-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | フリバンセリンの製剤及びその製造方法 |
CL2007002214A1 (es) | 2006-08-14 | 2008-03-07 | Boehringer Ingelheim Int | Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp |
CN101505736A (zh) * | 2006-08-25 | 2009-08-12 | 贝林格尔.英格海姆国际有限公司 | 控制释放系统及其制造方法 |
EP1894561A1 (en) * | 2006-08-30 | 2008-03-05 | Dr. Reddy's Laboratories Ltd. | Dipyridamole pharmaceutical compositions |
US20100093754A1 (en) * | 2007-03-28 | 2010-04-15 | Boehringer Ingelheim International Gmbh | Pharmaceutical Compositions Comprising Flibanserin and a Further Agent in the Treatment of Sexual Disorders |
PE20091188A1 (es) | 2007-09-12 | 2009-08-31 | Boehringer Ingelheim Int | Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen |
WO2009038708A1 (en) * | 2007-09-19 | 2009-03-26 | Combinatorx, Incorporated | Therapeutic regimens for the treatment of immunoinflammatory disorders |
KR20100121601A (ko) * | 2007-12-17 | 2010-11-18 | 콤비네이토릭스, 인코포레이티드 | 면역염증성 질환의 치료를 위한 치료요법 |
WO2009085306A1 (en) | 2007-12-28 | 2009-07-09 | Impax Laboratories, Inc. | Controlled release formulations of levodopa and uses thereof |
US20090196935A1 (en) * | 2008-02-01 | 2009-08-06 | Ahmed Salah U | Pharmaceutical Capsules Comprising Extended Release Dipyridamole Pellets |
US8133506B2 (en) * | 2008-03-12 | 2012-03-13 | Aptalis Pharmatech, Inc. | Drug delivery systems comprising weakly basic drugs and organic acids |
US20100080846A1 (en) * | 2008-09-25 | 2010-04-01 | Avshalom Ben-Menachem | Dipyridamole and acetylsalicylic acid formulations and process for preparing same |
JP2012523428A (ja) * | 2009-04-09 | 2012-10-04 | アルカーメス ファーマ アイルランド リミテッド | 放出制御クロザピン組成物 |
US20110003005A1 (en) * | 2009-07-06 | 2011-01-06 | Gopi Venkatesh | Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions |
EP2361615A1 (en) | 2010-02-19 | 2011-08-31 | Alfred E. Tiefenbacher GmbH & Co. KG | Dipyridamole prolonged-release tablet |
EP3782614A1 (en) | 2013-10-07 | 2021-02-24 | Impax Laboratories, LLC | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
US10987313B2 (en) | 2013-10-07 | 2021-04-27 | Impax Laboratories, Llc | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
CN105640909B (zh) | 2014-11-14 | 2019-09-20 | 正大天晴药业集团股份有限公司 | 一种含有达比加群酯的药用组合物 |
US11986449B2 (en) | 2020-12-22 | 2024-05-21 | Amneal Pharmaceuticals Llc | Levodopa dosing regimen |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2853420A (en) * | 1956-01-25 | 1958-09-23 | Lowey Hans | Ethyl cellulose coatings for shaped medicinal preparations |
US2928770A (en) * | 1958-11-28 | 1960-03-15 | Frank M Bardani | Sustained action pill |
US3081233A (en) * | 1960-08-08 | 1963-03-12 | Upjohn Co | Enteric-coated pilules |
US3247066A (en) * | 1962-09-12 | 1966-04-19 | Parke Davis & Co | Controlled release dosage form containing water-swellable beadlet |
NL297631A (pl) * | 1963-06-03 | |||
US3538214A (en) * | 1969-04-22 | 1970-11-03 | Merck & Co Inc | Controlled release medicinal tablets |
DE2010416B2 (de) * | 1970-03-05 | 1979-03-29 | Hoechst Ag, 6000 Frankfurt | Oral anwendbare Arzneiform mit Retardwirkung |
DE2031871C3 (de) * | 1970-06-27 | 1974-06-27 | Roehm Gmbh, 6100 Darmstadt | Überzugsmasse für Arzneiformen |
US3954959A (en) * | 1973-03-28 | 1976-05-04 | A/S Alfred Benzon | Oral drug preparations |
GB1468172A (en) * | 1973-03-28 | 1977-03-23 | Benzon As Alfred | Oral drug preparations |
DE2336218C3 (de) | 1973-07-17 | 1985-11-14 | Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz | Orale Arzneiform |
GB1479655A (en) | 1974-03-08 | 1977-07-13 | Beecham Group Ltd | Antibiotic preparations |
FR2353285A1 (fr) * | 1975-09-17 | 1977-12-30 | Doms Laboratoires | Medicament vasodilatateur coronarien perfectionne |
GB1576376A (en) * | 1977-03-30 | 1980-10-08 | Benzon As Alfred | Multiple-unit drug dose |
LU77353A1 (pl) * | 1977-05-16 | 1979-01-19 | ||
DD146547A5 (de) * | 1978-07-15 | 1981-02-18 | Boehringer Sohn Ingelheim | Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen |
DE2950977A1 (de) * | 1978-12-22 | 1980-07-10 | Donald E Panoz | Neue galenische zubereitungsform fuer die orale verabreichung von medikamenten mit programmierter besetzung, sowie verfahren zu ihrer herstellung |
-
1980
- 1980-01-12 DE DE19803000979 patent/DE3000979A1/de not_active Withdrawn
- 1980-12-12 IN IN896/DEL/80A patent/IN155158B/en unknown
- 1980-12-17 AT AT80107963T patent/ATE6585T1/de active
- 1980-12-17 EP EP80107963A patent/EP0032562B1/de not_active Expired
- 1980-12-17 DE DE8080107963T patent/DE3067058D1/de not_active Expired
- 1980-12-31 US US06/221,834 patent/US4367217A/en not_active Expired - Lifetime
-
1981
- 1981-01-09 IE IE40/81A patent/IE50807B1/en not_active IP Right Cessation
- 1981-01-09 NO NO810061A patent/NO157369C/no not_active IP Right Cessation
- 1981-01-09 ES ES498393A patent/ES8207428A1/es not_active Expired
- 1981-01-09 GB GB8100632A patent/GB2067073B/en not_active Expired
- 1981-01-09 DD DD81226911A patent/DD156943A5/de not_active IP Right Cessation
- 1981-01-09 PL PL1981229157A patent/PL129290B1/pl unknown
- 1981-01-09 CA CA000368242A patent/CA1148084A/en not_active Expired
- 1981-01-09 YU YU39/81A patent/YU42549B/xx unknown
- 1981-01-09 NZ NZ195994A patent/NZ195994A/en unknown
- 1981-01-09 GR GR63825A patent/GR73102B/el unknown
- 1981-01-09 DK DK009481A patent/DK158539C/da not_active IP Right Cessation
- 1981-01-09 IL IL61887A patent/IL61887A/xx not_active IP Right Cessation
- 1981-01-09 PT PT72330A patent/PT72330B/pt unknown
- 1981-01-09 FI FI810058A patent/FI78835C/fi not_active IP Right Cessation
- 1981-01-12 JP JP303881A patent/JPS56103111A/ja active Granted
- 1981-01-12 HU HU8168A patent/HU184366B/hu unknown
- 1981-01-12 OA OA57296A patent/OA06720A/xx unknown
- 1981-01-12 CS CS81232A patent/CS232713B2/cs unknown
- 1981-01-12 PH PH25080A patent/PH17063A/en unknown
- 1981-01-12 AR AR283919A patent/AR221983A1/es active
- 1981-01-12 MA MA19241A patent/MA19040A1/fr unknown
- 1981-01-12 AU AU66156/81A patent/AU539618B2/en not_active Expired
- 1981-01-12 ZA ZA008101661A patent/ZA811661B/xx unknown
-
1984
- 1984-04-04 SG SG281/84A patent/SG28184G/en unknown
- 1984-04-12 KE KE3402A patent/KE3402A/xx unknown
- 1984-08-09 HK HK621/84A patent/HK62184A/xx not_active IP Right Cessation
-
1985
- 1985-12-30 MY MY559/85A patent/MY8500559A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO157369C (no) | Fremgangsmaate for fremstilling av en dipyridamol-retardform. | |
NO159061C (no) | Fremgangsmaate for fremstilling av en bromhexin-retardform. | |
NO813726L (no) | Fremgangsmaate for fremstilling av piperazinyl-benzo-heterocykliske forbindelser | |
NO158993C (no) | Fremgangsmaate ved fremstilling av en gel. | |
NO813208L (no) | Fremgangsmaate for fremstilling av 3-aryl-5-isotiazol-derivater. | |
NO154821C (no) | Fremgangsmaate for fremstilling av et bacampicillinpreparat | |
DK499081A (da) | Kornformig laegemiddel-retardform | |
NO811811L (no) | Fremgangsmaate for fremstilling av papir. | |
NO810610L (no) | Fremgangsmaate for fremstilling av piperidinderivater | |
NO159341C (no) | Fremgangsmaate for fremstilling av en farvet, fast gjenstand. | |
RO82032A (ro) | Procedeu pentru prepararea cis-izocitratului de(a,2-diamino-ciclohexan)-plastina | |
NO801416L (no) | Forpakning for pulverformige materialer. | |
NO813442L (no) | Fremgangsmaate for fremstilling av 2-guanidin-4-heteroaryltiazolderivater | |
NO154495C (no) | Analogifremgangsmaate for fremstilling av en benzopyranforbindelse. | |
NO152894C (no) | Fremgangsmaate ved fremstilling av ureapellets. | |
NO822410L (no) | Fremgangsmaate ved fremstilling av benzothiazolsulfonamid-derivater. | |
IT7926561A0 (it) | Procedimento per preparare un copolimero. | |
NO820980L (no) | Fremgangsmaate for fremstilling av imidazo-pyrimidin-derivater | |
IT7926370A0 (it) | Procedimento per preparare un copolimero. | |
NO812841L (no) | Fremgangsmaate til fremstilling av florerte pentendiaminderivater | |
SE7908629L (sv) | Ett nytt forfarande for framstellning av 6-piperidino-2,4-diaminopyrimidin-3-oxid | |
NO157143C (no) | Fremgangsmaate for fremstilling av karbapen-2-em-derivater. | |
NO801659L (no) | Fremgangsmaate ved fremstilling av 10,11-dihydro-5h-dibenzo-(a,d,)-cyclohepten-5,10-iminer | |
ES507939A0 (es) | Un procedimiento de preparacion de nuevos derivados de la hidroxifenil-tetrahidropiridina . | |
NO774503L (no) | Fremgangsmaate for fremstilling av oktahydro-indolo(2,3,a)-chinoliziner |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |
Free format text: EXPIRED IN JANUARY 2001 |
|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN JANUARY 2001 |